Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119944) titled 'A single-arm, single-center, phase II prospective clinical study of I125 radioactive particle stent combined with immune checkpoint inhibitors for the treatment of advanced esophageal squamous cell carcinoma' on March 5.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Daping Hospital, Army Medical University
Condition:
Esophageal Squamous Cell Carcinoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-03-05
Target Sample Size: Experimental group:22;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=...